Price T Rowe Associates Inc Elanco Animal Health Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 28,067,722 shares of ELAN stock, worth $361 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
28,067,722
Previous 22,139,018
26.78%
Holding current value
$361 Million
Previous $360 Million
12.37%
% of portfolio
0.05%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
480MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.07 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$679 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$636 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$300 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A617.9MShares$230 Million9.66% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.1B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...